Summit-backed Viroclinics acquires DDL

Bob van Gemen, CEO of Viroclinics Biosciences, will serve as CEO of the combined organisation.

The combined group intends to increase laboratory capacity to create a complete portfolio of services, including early-stage pre-clinical work, large-scale phase 2/3 trials and post-marketing studies. The business will employ 240 scientists, researchers, technicians and support staff.

Summit Partners acquired Viroclinics Biosciences in March 2020. Summit managing director Thomas Tarnowski joined the Viroclinics board of directors.

Company
Founded in 1994, DDL is a laboratory specialising in diagnostic testing and diagnostic assay development. It performs testing on behalf of pharmaceutical companies and clinical laboratories. The company is based in Rijswijk and has 80 employees.

People
Viroclinics Biosciences – Bob van Gemen (CEO).
DDL Diagnostic Laboratory – Jan Lindeman (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• Benelux
• Healthcare
• Netherlands
• Summit Partners